Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of the Efficacy of Prophylaxis with Atorvastatin Versus Sodium Valproate on Intensity and Frequency of Migraine Type Headache in Iranian Patients

Next Previous
Search
Trial Profile

Comparison of the Efficacy of Prophylaxis with Atorvastatin Versus Sodium Valproate on Intensity and Frequency of Migraine Type Headache in Iranian Patients

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atorvastatin (Primary) ; Valproate semisodium (Primary)
  • Indications Migraine
  • Focus Therapeutic Use

    • Most Recent Events

    • 21 May 2018 New source identified and integrated (Iranian Registry of Clinical Trials IRCT2014092410178N8)
    • 21 May 2018 New trial record
    • 01 May 2018 Results (n=82) published in the Clinical Neuropharmacology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top